alexa Biodegradable, Biocompatible And Functional Pentablock Copolymer Based Nanoformulations For Sustained Ocular Delivery Of Macromolecules | 20859
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th International Conference on Clinical & Experimental Ophthalmology

Vibhuti Agrahari
Posters: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.S1.018
Abstract
Vision threatening disorders such as age-related macular degeneration (wet-AMD), diabetic retinopathy (DR) and diabetic macular edema (DME) require frequent intravitreal injections of anti-VEGF antibodies or fragments thereof. Frequent intravitreral injections are associated with many complications such as secondary infections (endophthalmitis), retinal hemorrhage, retinal detachment and more importantly patient non-compliance. Therefore, development of sustained release formulation which can reduce the frequency of intravitreal injection is a better therapeutic option. The objective of this study is to evaluate tolerability and biocompatibility of novel PB copolymers based formulations including thermosensitive gel, nanoparticles (NPs) and a composite formulation comprising NPs dispersed in gel following topical instillation as well as single intravitreal injection in rabbits. In this study, NP preparation method was successfully optimized to improve entrapment efficiency (EE) and drug loading (DL) of model macromolecules such as IgGFab and Catalase. With this optimized method, a remarkably improved EE (~ 46% to 76%) and DL (~15% to 18%) have been observed. Results of in vitro studies depicted a nearly zero order release for significantly longer duration of time (~120 days) without showing any burst release effect. Moreover, in vitro biocompatibility assay exhibited negligible release of cytokines suggesting biocompatible nature of PB copolymers. Further, in vivo tolerability study was performed following topical instillation and intravitreal injection. Results of in vivo tolerability study exhibited excellent biocompatibility without any perceptible signs of inflammation or cataract. Results revealed that PB copolymer based formulation can be used as a platform for the treatment of posterior segment ocular diseases
Biography
Vision threatening disorders such as age-related macular degeneration (wet-AMD), diabetic retinopathy (DR) and diabetic macular edema (DME) require frequent intravitreal injections of anti-VEGF antibodies or fragments thereof. Frequent intravitreral injections are associated with many complications such as secondary infections (endophthalmitis), retinal hemorrhage, retinal detachment and more importantly patient non-compliance. Therefore, development of sustained release formulation which can reduce the frequency of intravitreal injection is a better therapeutic option. The objective of this study is to evaluate tolerability and biocompatibility of novel PB copolymers based formulations including thermosensitive gel, nanoparticles (NPs) and a composite formulation comprising NPs dispersed in gel following topical instillation as well as single intravitreal injection in rabbits. In this study, NP preparation method was successfully optimized to improve entrapment efficiency (EE) and drug loading (DL) of model macromolecules such as IgGFab and Catalase. With this optimized method, a remarkably improved EE (~ 46% to 76%) and DL (~15% to 18%) have been observed. Results of in vitro studies depicted a nearly zero order release for significantly longer duration of time (~120 days) without showing any burst release effect. Moreover, in vitro biocompatibility assay exhibited negligible release of cytokines suggesting biocompatible nature of PB copolymers. Further, in vivo tolerability study was performed following topical instillation and intravitreal injection. Results of in vivo tolerability study exhibited excellent biocompatibility without any perceptible signs of inflammation or cataract. Results revealed that PB copolymer based formulation can be used as a platform for the treatment of posterior segment ocular diseases
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7